The TGF-beta and RAS signaling pathways work together to spur the spread of cancer in lung ... Most prostate cancers are ...

It is administered through subcutaneous route. The drug candidate is a protein which is an engineered ligand trap comprised of a modified ligand-binding domain of the TGF-beta receptor, activin ...

Beyond anti-inflammatory treatments, Enveda is developing candidates across multiple therapeutic areas, including small molecules for amyotrophic lateral sclerosis (ALS), Parkinson’s disease, fibrosis ...